HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dubinsky, R. M. Articles by Ali, H. Search for Related Content PubMed PubMed Citation Articles by Dubinsky, R. M. Articles by Ali, H. Related Collections Peripheral neuropathy Clinical trials Systematic review/meta analysis All Pain Neuropathic pain

Practice Parameter: Treatment of postherpetic neuralgia

An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology^*

Address correspondence and reprint requests to the American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116-2325.

A systematic review of the literature on postherpetic neuralgia was performed. The authors identified studies using the National Library of Medicine’s Medline database and Cochrane Library database. The authors determined absolute reduction rate, number needed to treat (NNT), 95% CI for NNT, and number needed to harm (NNH) for successful therapies of postherpetic neuralgia. Tricyclic antidepressants, gabapentin, pregabalin, opioids, and lidocaine patch were found to be effective in reducing the pain of postherpetic neuralgia.

Received October 3, 2001. Accepted in final form May 20, 2004.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the September 28 issue to find the title link for this article.

*Members of the Quality Standards Subcommittee are listed in the Appendix on page 964.

Approved by the QSS in October 2003 and by the Practice Committee in November 2003. Approved by the AAN Board of Directors in June 2004.

This article has been cited by other articles:

				J. Katz, N. B. Finnerup, and R. H. Dworkin Clinical trial outcome in neuropathic pain: Relationship to study characteristics Neurology, January 22, 2008; 70(4): 263 - 272. [Abstract] [Full Text] [PDF]

				N. M. Gajraj Pregabalin: Its Pharmacology and Use in Pain Management Anesth. Analg., December 1, 2007; 105(6): 1805 - 1815. [Abstract] [Full Text] [PDF]

				M.-Y. Cheung and M. Viney A Unique Case of Recurrent Asystole Secondary to Paroxysmal Pain of Acute Herpetic Ophthalmicus Anesth. Analg., October 1, 2007; 105(4): 1127 - 1129. [Abstract] [Full Text] [PDF]

				J.B. Epstein, S. Elad, E. Eliav, R. Jurevic, and R. Benoliel Orofacial Pain in Cancer: Part II--Clinical Perspectives and Management J. Dent. Res., June 1, 2007; 86(6): 506 - 518. [Abstract] [Full Text] [PDF]

				J. M. Hauer, B. S. Wical, and L. Charnas Gabapentin Successfully Manages Chronic Unexplained Irritability in Children With Severe Neurologic Impairment Pediatrics, February 1, 2007; 119(2): e519 - e522. [Abstract] [Full Text] [PDF]

				B. F Shneker and J. W McAuley Pregabalin: A New Neuromodulator with Broad Therapeutic Indications Ann. Pharmacother., December 1, 2005; 39(12): 2029 - 2037. [Abstract] [Full Text] [PDF]

				R. B. Tenser and R. H. Dworkin Herpes zoster and the prevention of postherpetic neuralgia: Beyond antiviral therapy Neurology, August 9, 2005; 65(3): 349 - 350. [Full Text] [PDF]

				American Academy of Neurology Practice Parameter: New Drugs, and Some Old Ones, Effective for Postherpetic Neuralgia Journal Watch Neurology, November 29, 2004; 2004(1129): 1 - 1. [Full Text]